Mounjaro's price change in 2026: what it means for your treatment costs

You've just looked up the price and you're not sure what you're looking at

That's a reasonable reaction. Mounjaro prices in the UK vary quite a bit by provider and by dose, and since Eli Lilly raised its list pricing from 1 September 2025, the figures have shifted considerably from what many patients remember. If you want to understand exactly what shifted and when, our page covering the Mounjaro price change walks through what Lilly announced and what it meant in practice. Reported market prices for private Mounjaro treatment in the UK now typically range from roughly £149 to £375 per month, depending on the dose and the service providing it, as widely reported in August and September 2025 following Lilly's announcement.

The dose matters a lot here. Treatment starts at 2.5mg, which is a tolerability dose designed to let your system adjust before the prescriber moves you up; later doses carry a higher cost. So the monthly figure you see advertised is often the starter price, not what you'd pay at 10mg or 15mg. That gap is worth understanding before you commit to any provider.

You can explore the broader context of how Mounjaro is priced in the UK on our Mounjaro cost overview page, which covers the dose-by-dose picture in more detail. And for a fuller account of what the September 2025 increase involved, the history of Mounjaro price changes is worth reading alongside this.

What typical headline prices often leave out

A price you see listed for Mounjaro online may or may not include the consultation fee, the prescription charge, delivery, and any ongoing clinical support. Some providers charge each of these separately. Others bundle them but apply a subscription model that auto-renews unless you actively cancel.

Worth asking before you order: is the consultation free or charged? Is there a separate prescription fee? What happens if you need to pause or switch doses, is there a clinical review, and does it cost extra? Is aftercare available seven days a week, or only by email during office hours?

These aren't trivial questions. Mounjaro is a prescription medicine, meaning its use requires ongoing clinical oversight, not just an initial tick-box. The NICE appraisal of tirzepatide (NICE TA1026) sets out the clinical framework for this treatment, and it's worth knowing that genuine safety infrastructure costs something to run. A price that seems unusually low usually means something has been stripped out.

Where nume sits on price, and why we're honest about it

We're not the cheapest option on the market. That's a deliberate call. One price covers your consultation, the prescriber's review, your prescription, treatment itself, next-working-day delivery, and aftercare seven days a week. Nothing extra appears at checkout. There is no subscription. Every repeat order gets a fresh clinical review before it's approved and dispatched.

If you order by noon on a weekday and your case is clinically approved that day, your treatment goes out the same afternoon with DPD. The next morning you'll get a tracking notification; the pen arrives in a plain, unmarked box, nothing on the outside to suggest what's inside. The pen itself is Lilly's KwikPen: pre-filled, once-weekly, no needle to attach.

Current treatment pricing is shown on our treatment page, we don't list per-pen prices in article copy because the right dose, and therefore the right price, depends on a clinical conversation first. What you see there is the full picture: no footnotes.

Our prescribers (you can read more about our clinical team on the clinical lead's profile page) are GPhC-registered Independent Prescribers. That matters because the GPhC register is publicly searchable; you can verify any online pharmacy at our GPhC registration page.

Why 'cheapest' is the wrong question for a prescription medicine

The MHRA has been clear that GLP-1 medicines are not assessed for quick or cosmetic weight loss, and that these are prescription-only medicines requiring proper clinical assessment. They have also warned (publicly and repeatedly) about counterfeit Mounjaro and other weight-loss pens sold online, including fake pens that have been found to contain insulin rather than tirzepatide. The MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk lets you report any suspect seller or product.

Red flags to watch for: sellers offering Mounjaro without requiring a prescription or medical assessment, prices far below the market range described above, discount codes promoted through social media, and delivery from outside the licensed UK supply chain. If you want to see how legitimate providers currently stack up against one another, our Mounjaro price comparison for 2026 sets out what different services are charging and what is included at each price point. A legitimate provider's price reflects legitimate infrastructure. That infrastructure (prescriber time, pharmacy registration, genuine medicine sourced through authorised UK channels, clinical aftercare) is what actually keeps you safe.

For a treatment that affects how your body processes food and regulates appetite, the real question isn't which provider charges the least. It's which provider you'd trust with your health over the months this medicine is part of your life. Our page on Mounjaro prices in 2026 gives a current overview of what patients across the UK are paying and what to expect going forward, and our separate page on the Mounjaro price decrease in 2026 explains the recent reductions some providers have made and what is driving them. If you'd like to talk to a real prescriber about whether Mounjaro is right for you, start your free consultation and we'll review your case the same day.